Journal of Clinical Investigation
hideThe Journal of Clinical Investigation (JCI or J Clin Invest) is a leading biomedical journal, with a 2008 impact factor of 16.559. The journal makes its research articles -- including access to articles back to 1924 -- freely available online.
The website of the journal describes it as "a premier venue for critical advances in biomedical research, authoritative reviews, and commentaries that place research articles in context." The first issue of the journal appeared in 1924, and within a few decades, it had established itself as a reputed journal for primary clinical research.
The JCI's Editorial Board is unique in that its members are located chiefly at a singular academic medical center and are predominantly members of the American Society for Clinical Investigation. The leadership of the Editorial Board changes every five years: As of March 2007, the Editorial Board is located at the University of Pennsylvania under the leadership of Laurence A. Turka, M.D. From March 2002 to March 2007, the Editorial Board was located at Columbia University under the leadership of Andrew Marks, M.D. Ushma S. Neill, formerly with Nature Medicine, is the journal's Executive Editor.
This monthly journal publishes original research and review articles, including periodic review series focusing on important topics in biomedicine.
For more information about Journal of Clinical Investigation, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with journal of clinical investigation
Why Some Monkeys Don't Get AIDS
Medicine & Health / HIV & AIDS
Dec 03, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two studies published this month in the Journal of Clinical Investigation provide a significant advance in understanding how some species of monkeys such as sooty mangabeys and African green ...
Scientists identify possible therapy target for aggressive cancer
Dec 01, 2009 |
5 / 5 (1) |
0
UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF-ß1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after ...
Scientists discover cells that control inflammation in chronic disease
Nov 17, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time ...
Researchers find inflammation critical in aortic dissection
Nov 16, 2009 |
not rated yet |
0
The aorta, the body's largest artery, stretches from the chest to below the kidneys, expanding and contracting with the pressure of blood driven directly into it by the heart. Although its walls are extraordinarily strong, ...
Wistar researchers show targeting 'normal' cells in tumors slows growth
Nov 16, 2009 |
1 / 5 (1) |
0
Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.
Study provides first clear idea of how rare bone disease progresses
Nov 12, 2009 |
5 / 5 (1) |
0
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ...
Death-inducing proteins key to complications of bone marrow transplantation
Dec 01, 2009 |
not rated yet |
0
Treatment for a number of cancers and other medical conditions is transplantation with bone marrow from a genetically nonidentical individual (a process known as allogeneic bone marrow transplantation [allo-BMT]).
Watching Lyme disease-causing microbes move in ticks
Nov 16, 2009 |
not rated yet |
0
Lyme disease is caused by the microbe Borrelia burgdorferi, which is transmitted to humans from feeding ticks.
NSAIDs prevent early sign of Alzheimer disease in mice
Nov 09, 2009 |
not rated yet |
0
If taking nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen or naproxen is to protect you from developing Alzheimer disease then you will have to start taking them at a very early age according to new research ...
